B

Baksh, M. F. ORCID: https://orcid.org/0000-0003-3107-8815, Böhning, D. and Lerdsuwansri, R. (2011) An extension of an over-dispersion test for count data. Computational Statistics & Data Analysis, 55 (1). pp. 466-474. ISSN 0167-9473 doi: 10.1016/j.csda.2010.05.015

Burn, R., Underwood, F. and Blanc, J. (2011) Global trends and factors associated with the illegal killing of elephants: a hierarchical bayesian analysis of carcass encounter data. PLoS ONE, 6 (9). e24165. ISSN 1932-6203 doi: 10.1371/journal.pone.0024165

C

Chataway, J., Nicholas, R., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X, Miller, D. H., Parsons, N., Valdes-Marquez, E., Stallard, N. and Friede, T. (2011) A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis. Multiple Sclerosis Journal, 17 (1). pp. 81-88. ISSN 1477-0970 doi: 10.1177/1352458510382129

D

Didelot, X., Everitt, R. G., Johansen, A. M. and Lawson, D. J. (2011) Likelihood-free estimation of model evidence. Bayesian Analysis, 6 (1). pp. 49-76. ISSN 1931-6690 doi: 10.1214/11-BA602

F

Friede, T., Parsons, N., Stallard, N., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X, Valdes Marquez, E., Chataway, J. and Nicholas, R. (2011) Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis. Statistics in Medicine, 30 (13). pp. 1528-1540. ISSN 1097-0258 doi: 10.1002/sim.4202

J

James, G., Zhou, Y. and Miller, S. (2011) Modeling data with structural and temporal correlation using lower level and higher level multilevel models. Pharmaceutical Statistics, 10 (5). pp. 395-406. ISSN 1539-1612 doi: 10.1002/pst.479

M

Matcham, J., Julious, S., Pyke, S., O'Kelly, M., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X, Seldrup, J. and Day, S. (2011) Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Pharmaceutical Statistics, 10 (1). pp. 70-73. ISSN 1539-1612 doi: 10.1002/pst.417

N

Neuman, B. W., Kiss, G., Kunding, A. H., Bhella, D., Baksh, M. F. ORCID: https://orcid.org/0000-0003-3107-8815, Connelly, S., Droese, B., Klaus, J. P., Makino, S., Sawicki, S. G., Siddell, S. G., Stamou, D. G., Wilson, I. A., Kuhn, P. and Buchmeier, M. J. (2011) A structural analysis of M protein in coronavirus assembly and morphology. Journal of Structural Biology, 174 (1). pp. 11-22. ISSN 1047-8477 doi: 10.1016/j.jsb.2010.11.021

O

O'Kelly, M., Julious, S. A., Pyke, S., Day, S., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X, Seldrup, J. and Matcham, J. (2011) Making available information from studies sponsored by the pharmaceutical industry: some current practices. Pharmaceutical Statistics, 10 (1). pp. 60-69. ISSN 1539-1612 doi: 10.1002/pst.430

P

Pyke, S., Julious, S. A., Day, S., O'Kelly, M., Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X, Matcham, J. and Seldrup, J. (2011) The potential for bias in reporting of industry-sponsored clinical trials. Pharmaceutical Statistics, 10 (1). pp. 74-79. ISSN 1539-1612 doi: 10.1002/pst.429

S

Stallard, N. and Todd, S. ORCID: https://orcid.org/0000-0002-9981-923X (2011) Seamless phase II/III designs. Statistical Methods in Medical Research, 20 (6). pp. 623-634. ISSN 0962-2802 doi: 10.1177/0962280210379035

Z

Zhou, Y. (2011) Randomized dose-finding studies: how many dose levels should be used? Clinical Investigation, 1 (8). pp. 1061-1063. ISSN 2041-6792 doi: 10.4155/cli.11.81